Loading
Loading…
New
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Offered Item | Rank |
|---|---|---|---|
| 1 | Not yet disclosed by govt. L1 Item Categories: inj Epidosin,Inj Heamaceel,Catgut 2 No,Inj Gravidol,Inj Transtate | Item Categories: inj Epidosin,Inj Heamaceel,Catgut 2 No,Inj Gravidol,Inj Transtate | L1 |
| 2 | Not yet disclosed by govt. L2 Item Categories: inj Epidosin,Inj Heamaceel,Catgut 2 No,Inj Gravidol,Inj Transtate | Item Categories: inj Epidosin,Inj Heamaceel,Catgut 2 No,Inj Gravidol,Inj Transtate | L2 |
Tender Value
₹5 L
EMD Value
Exempted
Closing Date
8 Sept 2025, 1:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
inj Epidosin
Inj Heamaceel
Catgut 2 No
Inj Gravidol
Inj Transtate
8232345
GEM/2025/B/6579185
Single Packet Bid
inj Epidosin
20 days
AHMAD TEELI192126BMO LARNOO
Total value wise evaluation
BOQ
4 documents required · 4 mandatory
10%
Exempted
8 Sept 2025
18 Aug 2025
8 Sept 2025
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8232345.pdf
GEM_BID
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
pdf_file_2025-08-18-12-09-57_e9ac36421ab8ad6490add508731f01dc.pdf
BOQ
boq_cvs_larnoo_2025-08-18-12-09-57_085552156508e38779cb6136071be1fd.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .